logo
Kansas coach Bill Self released from hospital after undergoing heart procedure

Kansas coach Bill Self released from hospital after undergoing heart procedure

Kansas men's basketball coach Bill Self was released from the hospital Saturday following a procedure to insert two stents, the school announced. Self had checked into Lawrence Memorial Hospital on Thursday after experiencing 'concerning symptoms' and feeling unwell.
'I want to thank all the amazing doctors and nurses at LMH Health for the excellent care I received during my stay,' Self said in a statement. 'I feel strong and am excited to be home. Our team has had a productive summer, and I'm looking forward to recharging and preparing for the upcoming season.'
Advertisement
This marks the second heart-related procedure for the 62-year-old coach in just over two years. In March 2023, Self underwent a heart catheterization and had two stents placed to treat blocked arteries, causing him to miss the Big 12 and NCAA Tournaments. Kansas, a No. 1 seed that year, was eliminated in the second round by No. 8 Arkansas.
At the time, Self had reported chest tightness and balance issues, prompting immediate medical attention.
Self has typically been a steady presence on the Kansas sideline since taking over in 2003, missing only a handful of games.
Despite the health setbacks, Self remains one of the most accomplished coaches in the sport. He signed a $53 million deal in 2023, making him the highest-paid coach in college basketball.
In 2017, he was inducted into the Naismith Memorial Basketball Hall of Fame and is entering his 33rd season as a head coach. Self holds an 831-261 career record with four Final Four appearances and two national championships on his resume.
The Jayhawks open the season Nov. 3 against Wisconsin-Green Bay.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group (UNH) Responds to the Department of Justice

Yahoo

time25 minutes ago

  • Yahoo

UnitedHealth Group (UNH) Responds to the Department of Justice

UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Marco Wilson injury: Bengals defensive back hurt during training camp, could miss weeks
Marco Wilson injury: Bengals defensive back hurt during training camp, could miss weeks

Yahoo

time25 minutes ago

  • Yahoo

Marco Wilson injury: Bengals defensive back hurt during training camp, could miss weeks

Cincinnati Bengals defensive back Marco Wilson suffered an apparent injury during training camp near Paycor Stadium. Bengals head coach Zac Taylor didn't provide details about Wilson's injury after Sunday's practice, but did designate Wilson as "week to week" because of it. During the Bengals' Week 16 win against Cleveland in 2024, head coach Zac Taylor didn't appear to be happy with officials after Wilson was flagged for defensive pass interference for his coverage of Browns receiver Jerry Jeudy during the third quarter. The Bengals claimed Wilson off waivers in November 2024. Wilson, a fourth-round pick out of Florida in the 2021 NFL draft, also has played for the New England Patriots and the Arizona Cardinals. This article originally appeared on Cincinnati Enquirer: Marco Wilson injury: Bengals DB week to week with unspecified issue

Cancer Care Costs High Among Privately Insured Patients
Cancer Care Costs High Among Privately Insured Patients

Medscape

time27 minutes ago

  • Medscape

Cancer Care Costs High Among Privately Insured Patients

TOPLINE: A recent analysis found that privately insured US patients with newly diagnosed cancer, especially those with more advanced disease, had 'substantial out-of-pocket costs.' Monthly out-of-pocket costs among these patients increased by a mean of almost $600, on average, but increased to nearly $720 per month for those with stage IV disease. METHODOLOGY: Out-of-pocket costs for cancer care in the US are rising, but most research has focused on Medicare beneficiaries. It's important to understand privately insured patients' financial burdens, especially with cancer rates growing among younger Americans. Researchers conducted a retrospective study of 19,656 patients with cancer, using a dataset that links claims from a large private insurer to the Surveillance, Epidemiology, and End Results cancer registry. Overall, 74.1% had breast cancer, 14.5% had colorectal cancer, and 11.4% had lung cancer. Analyses also included 26,502 individuals without cancer who were assigned pseudo – diagnosis date. Monthly out-of-pocket costs (copays, co-insurance, and deductibles) were calculated from claims and inflation-adjusted to 2024 US dollars. TAKEAWAY: After a cancer diagnosis, monthly out-of-pocket costs rose by $592, on average. Those added costs increased with disease stage, from $462 per month for stage 0 cancer to $720 per month for stage IV cancer. Out-of-pocket costs spiked in the month of diagnosis and remained elevated for 6 months compared with those in individuals without cancer — totaling an average of $4145 in cumulative additional costs (over 7 months). IN PRACTICE: 'In this cohort study, patients with private insurance were found to have high OOPCs [out-of-pocket costs] after an incident diagnosis of cancer, and those with the most advanced cancer had the highest OOPCs,' the authors wrote. 'The variability in OOPCs based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer.' SOURCE: This study, led by Liam Rose, PhD, Stanford University School of Medicine, Palo Alto, California, was published online in JAMA Network Open. LIMITATIONS: Differential insurance attrition could have affected the results: Patients with stage IV cancer were most likely to drop their coverage. The study could only capture direct medical costs, which misses other potential financial burdens, such as lost income and travel expenses. DISCLOSURES: This study received funding support through a grant from the American Cancer Society. One author reported receiving grants from the Department of Veterans Affairs and National Institutes of Health during the conduct of the study. No other disclosures were reported. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store